Conventional or molecular measurement of Aspergillus load

Medical Mycology

Volumn 47, Issue SUPPL. 1, 2009, Pages

  Clemons, K V ^a,b,c   Stevens, D A ^a,b,c  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Aspergillus quantification; Chitin determination; Fungal burden in tissues; Galactomannan; RT PCR

Indexed keywords

AMPHOTERICIN B; BETA GLUCAN; CASPOFUNGIN; DNA 18S;

ANALYTIC METHOD; ARTICLE; ASPERGILLUS; CELL WALL; COLONY FORMING UNIT; CULTURE TECHNIQUE; DRUG DETERMINATION; DRUG EFFICACY; ENZYME IMMUNOASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; FUNGAL DETECTION; FUNGUS CULTURE; FUNGUS GROWTH; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TISSUE HOMOGENATE; BACTERIAL COUNT; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METHODOLOGY; REVIEW;

ASPERGILLUS;

ASPERGILLUS; COLONY COUNT, MICROBIAL; IMMUNOENZYME TECHNIQUES; POLYMERASE CHAIN REACTION;

EID: 67651125198     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802213340     Document Type: Article

References (52)

1. Fischer R.Nuclear movement in filamentous fungi FEMS Microbiol Rev 1999; 23: 39-68.
2. McIntyre M, Dynesen J, Nielsen J.Morphological characterization of Aspergillus nidulans: Growth, septation and fragmentation Microbiol 2001; 147: 239-246.
3. Momany M.Growth control and polarization Med Mycol 2005; 43 Suppl. 1): S23-25.
4. Momany M, Lindsey R, Hill TW, et al. The Aspergillus fumigatus cell wall is organized in domains that are remodelled during polarity establishment Microbiol 2004; 150: 3261-3268.
5. Momany M, Taylor I.Landmarks in the early duplication cycles of Aspergillus fumigatus and Aspergillus nidulans: Polarity, germ tube emergence and septation Microbiol 2000; 146: 3279-3284.
6. Suelmann R, Sievers N, Fischer R.Nuclear traffic in fungal hyphae: In vivo study of nuclear migration and positioning in Aspergillus nidulans Mol Microbiol 1997; 25: 757-769.
7. Katz D, Goldstein D, Rosenberger RF.Model for branch initiation in Aspergillus nidulans based on measurements of growth parameters J Bacteriol 1972; 109: 1097-1100.
8. Muller C, Spohr AB, Nielsen J.Role of substrate concentration in mitosis and hyphal extension of Aspergillus Biotechnol Bioeng 2000; 67 390-397.
9. Maruyama J, Kikuchi S, Kitamoto K.Differential distribution of the endoplasmic reticulum network as visualized by the BipAEGFP fusion protein in hyphal compartments across the septum of the filamentous fungus, Aspergillus oryzae Fungal Genet Biol 2006; 43: 642-654.
10. Wosten HA, Moukha SM, Sietsma JH, Wessels JG.Localization of growth and secretion of proteins in Aspergillus niger J Gen Microbiol 1991; 137: 2017-2023.
11. Restrepo A, Jimenez BE.Growth of Paracoccidioides brasiliensis yeast phase in a chemically defined culture medium J Clin Microbiol 1980; 12: 279-281.
12. Castaneda E, Brummer E, Perlman AM, McEwen JG, Stevens DA.A culture medium for Paracoccidioides brasiliensis with high plating efficiency, and the effect of siderophores J Med Vet Mycol 1988; 26: 351-358.
13. Nishikaku AS, Burger E.Evaluation of fungal burden in experimental paracoccidioidomycosis by using the fluorescent dye Blankophor J Clin Microbiol 2003; 41: 3419-3422.
14. Restrepo A, Cano LE, de Bedout C, Brummer E, Stevens DA.Comparison of various techniques for determining viability of Paracoccidioides brasiliensis yeast-form cells J Clinl Microbiol 1982; 16: 209-211.
15. Kwon-Chung KJ, Tewari RP.Determination of viability of Histoplasma capsulatum yeast cells grown in vitro: Comparison between dye and colony count methods J Med Vet Mycol 1987; 25: 107-114.
16. Latge JP. Aspergillus fumigatus and aspergillosis Clin Microbiol Rev 1999; 12: 310-350.
17. Maruyama J, Juvvadi PR, Ishi K, Kitamoto K.Three-dimensional image analysis of plugging at the septal pore by Woronin body during hypotonic shock inducing hyphal tip bursting in the filamentous fungus Aspergillus oryzae Biochem Biophys Res Commun 2005; 331: 1081-1088.
18. Singh G, Imai J, Clemons KV, Stevens DA.Efficacy of caspofungin against central nervous system Aspergillus fumigatus infection in mice determined by TaqMan PCR and CFU methods Antimicrob Agents Chemother 2005; 49: 1369-1376.
19. Lehmann PF, White LO.Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigatus mycelium in mice Infect Immun 1975; 12: 987-992.
20. Schmidt A.Animal models of aspergillosis - also useful for vaccination strategies? Mycoses 2002; 45: 38-40.
21. Chilvers ER, Spreadbury CL, Cohen J.Bronchoalveolar lavage in an immunosuppressed rabbit model of invasive pulmonary aspergillosis Mycopathologia 1989; 108: 163-171.
22. Spreadbury CL, Krausz T, Pervez S, Cohen J.Invasive aspergillosis: clinical and pathological features of a new animal model J Med Vet Mycol 1989; 27: 5-15.
23. Becker MJ, de Marie S, Fens MH, et al. Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response J Antimicrob Chemother 2005; 49: 813-820.
24. Balloy V, HuerreM, Latge JP, ChignardM.Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis Infect Immun 2005; 73: 494-503.
25. Sarfati J, Diaquin M, Debeaupuis JP, et al. A new experimental murine aspergillosis model to identify strains of Aspergillus fumigatus with reduced virulence Nippon Ishinkin Gakkai Zasshi 2002; 43: 203-213.
26. Marr KA, Balajee SA, McLaughlin L, et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: Variables that affect performance J Infect Dis 2004; 190: 641-649.
27. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (103) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans Clin Infect Dis 2005; 41: 654-659.
28. Pazos C, Ponton J, Del Palacio A.Contribution of (103)-beta-Dglucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: A comparison with serial screening for circulating galactomannan J Clin Microbiol 2005; 43: 299-305.
29. Donnelly JP.Polymerase chain reaction for diagnosing invasive aspergillosis: Getting closer but still a ways to go Clin Infect Dis 2006; 42: 487-489.
30. Loeffler J, Hebart H, Brauchle U, Schumacher U, Einsele H.Comparison between plasma and whole blood specimens for detection of Aspergillus DNA by PCR J Clin Microbiol 2000; 38: 3830-3833.
31. Loeffler J, Hebart H, Cox P, et al. Nucleic acid sequence-based amplification of Aspergillus RNA in blood samples J Clin Microbiol 2001; 39: 1626-1629.
32. Loeffler J, Henke N, Hebart H, et al. Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system J Clin Microbiol 2000; 38: 586-590.
33. White PL, Barnes RA. Aspergillus PCR-Platforms, strengths and weaknesses Med Mycol 2006; 44(Suppl. 1): S191-S198.
34. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA.The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting Clin Infect Dis 2006; 42: 479-486.
35. Costa C, Vidaud D, Olivi M, et al. Development of two real-time quantitative TaqMan PCR assays to detect circulating Aspergillus fumigatus DNA in serum J Microbiol Methods 2001; 44: 263-269.
36. Bowman JC, Abruzzo GK, Anderson JW, et al. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: Demonstration of efficacy of caspofungin acetate Antimicrob Agents Chemother 2001; 45: 3474-3481.
37. Bowman JC, Abruzzo GK, Flattery AM, et al. Efficacy of caspofungin against Aspergillus flavus, Aspergillus terreus, and Aspergillus nidulans Antimicrob Agents Chemother 2006; 50: 4202-4205.
38. Loeffler J, Kloepfer K, Hebart H, et al. Polymerase chain reaction detection of Aspergillus DNA in experimental models of invasive aspergillosis J Infect Dis 2002; 185: 1203-1206.
39. O'Sullivan CE, Kasai M, Francesconi A, et al. Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis J Clin Microbiol 2003; 41: 5676-5682.
40. Warn PA, Sharp A, Mosquera J, et al. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus J Antimicrob Chemother 2006; 58: 1198-1207.
41. Sheppard DC, Marr KA, Fredricks DN, et al. Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis Clin Microbiol Infect 2006; 12: 376-380.
42. Francis P, Lee JW, Hoffman A, et al. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: The potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection J Infect Dis 1994; 169: 356-368.
43. Petraitiene R, Petraitis V, Groll AH, et al. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: Correlation with galactomannan antigenemia Antimicrob Agents Chemother 2001; 45: 857-869.
44. Petraitiene R, Petraitis V, Groll AH, et al. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: Pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia Antimicrob Agents Chemother 2002; 46: 12-23.
45. Petraitiene R, Petraitis V, Lyman CA, et al. Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits Antimicrob Agents Chemother 2004; 48: 1188-1196.
46. Petraitis V, Petraitiene R, Groll AH, et al. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits Antimicrob Agents Chemother 2002; 46: 1857-1869.
47. Petraitis V, Petraitiene R, Sarafandi AA, et al. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin J Infect Dis 2003; 187: 1834-1843.
48. Walsh TJ, Petraitis V, Petraitiene R, et al. Experimental pulmonary aspergillosis due to Aspergillus terreus: Pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B J Infect Dis 2003; 188: 305-319.
49. Hashimoto A, Yamakami Y, Kamberi P, et al. Comparison of PCR, (103)-beta-D-glucan and galactomannan assays in sera of rats with experimental invasive aspergillosis J Clin Lab Anal 1998; 12 257-262.
50. Mitsutake K, Kohno S, Miyazaki T, et al. Detection of (1-3)-beta- D-glucan in a rat model of aspergillosis J Clin Lab Anal 1995; 9: 119-122.
51. Scotter JM, Chambers ST.Comparison of galactomannan detection, PCR-enzyme-linked immunosorbent assay, and real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model and effect of caspofungin acetate Clin Diagn Lab Immunol 2005; 12: 1322-1327.
52. Sheppard DC, Chabot J, Kirkpatrick WR, et al. Effect of antifungal agents on galactomannan kinetics in vivo. In: 47th Intersci Conf Antimicrob Agents Chemother; 17-20 September 2007; Chicago, IL: American Society of Microbiology; 2007: M-738.